At this time, our data suggest that an IL-18Rα-mediated signaling pathway, not via a TLR4 signaling pathway, in CD4+ T cells and APCs plays a major part in the immune response to LPS-induced AKI in the acute advanced phase. The gene discussed is CD4; the disease is acute kidney injury.